We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Episurf Medical AB (EPIS B) NPV B

Sell:0.14 SEK Buy:0.14 SEK Change: 0.0036 SEK (2.62%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.14 SEK
Buy:0.14 SEK
Change: 0.0036 SEK (2.62%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.14 SEK
Buy:0.14 SEK
Change: 0.0036 SEK (2.62%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Company’s product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the knee’s surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.

Contact details

Address:
Karlavagen 60
STOCKHOLM
114 49
Sweden
Telephone:
+46 (8) 6120020
Website:
https://episurf.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
EPIS B
ISIN:
SE0003491562
Market cap:
89.58 million SEK
Shares in issue:
651.48 million
Sector:
Health Care Equipment
Exchange:
Stockholm Stock Exchange
Country:
Sweden
Currency:
Swedish Krona
Indices:
n/a

Key personnel

  • Pal Ryfors
    Chief Executive Officer
  • Veronica Wallin
    Chief Financial Officer
  • Patrick Jamnik
    President of Episurf Medical Inc
  • Katarina Flodstrom
    Chief Operating Officer
  • Fredrik Zetterberg
    Marketing Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.